Thoracoscopic Organ Suffusion for Regional Lung Chemotherapy (Preliminary Results)

Annals of Thoracic Surgery

Volumn 88, Issue 2, 2009, Pages 385-391

  Demmy, Todd L ^a   Tomaszewski, Garin ^a   Dy, Grace K ^a   Yendamuri, Sai ^a   Nwogu, Chukwumere ^a   Pendyala, Lakshmi ^a   Ramnath, Nithya ^a   Adjei, Alex A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ATELECTASIS; BALLOON OCCLUSION; BONE METASTASIS; CANCER CHEMOTHERAPY; CARDIOPLEGIA; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DOSE RESPONSE; DRAIN; DRUG DOSE ESCALATION; DRUG INFUSION; DRUG TISSUE LEVEL; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LUNG ASPIRATION; LUNG COLLAPSE; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG PERFUSION; LUNG VENTILATION; MALE; MULTIPLE CYCLE TREATMENT; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION; PULMONARY VEIN OBSTRUCTION; REGIONAL PERFUSION; THORACOSCOPY; TUBE;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; DOGS; FEMALE; FLUOROSCOPY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; THORACOSCOPY;

EID: 67650759347     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.101     Document Type: Article

References (8)

1. Bartlett D.L., Libutti S.K., Figg W.D., Fraker D.L., and Alexander H.R. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 129 (2001) 176-187
2. Lienard D., Ewalenko P., Delmotte J.J., Renard N., and Lejeune F.J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10 (1992) 52-60
3. Grootenboers M.J., Heeren J., Van Putte B.P., et al. Isolated lung perfusion for pulmonary metastases, a review and work in progress. Perfusion 21 (2006) 267-276
4. Pass H.I., Mew D.J., Kranda K.C., Temeck B.K., Donington J.S., and Rosenberg S.A. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 61 (1996) 1609-1617
5. Weksler B., and Burt M. Isolated lung perfusion with antineoplastic agents for pulmonary metastases. Chest Surg Clin N Am 8 (1998) 157-182
6. Demmy T.L., Wagner-Mann C., and Allen A. Isolated lung chemotherapeutic infusions for treatment of pulmonary metastases: a pilot study. J Biomed Sci 9 (2002) 334-338
7. [No authors listed]. Common terminology criteria for adverse events (CTCAE) v3 (2009), National Cancer Institute. http://www.fda.gov/cder/cancer/toxicityframe.htm Available at: http://www.fda.gov/cder/cancer/toxicityframe.htm. Accessed May 26, 2009
8. Hess S.D., Egilmez N.K., Bailey N., et al. Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma. J Immunol 170 (2003) 400-412